Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Kadushkin, A. Tahanovich, T. Shman (Minsk, Belarus). Changes in the populations of blood T-lymphocytes containing chemokine receptors in non-smoking patients with COPD. Eur Respir J 2013; 42: Suppl. 57, 3897

Member's Comments

No comment yet.

Related content which might interest you: Regulatory T-lymphocytes in peripheral blood of never smoking patients with COPD Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung Year: 2013 Increased expression of ADRB2, CHRM3 and glucocorticoid alpha receptor genes in blood leukocytes of COPD patients Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 Expression of HLA-DR in circulating polymorphonuclear neutrophils of COPD patients Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Distribution of blood eosinophil in COPD patients Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 Macrophage migration inhibition factor in peripheral blood and induced sputum in patients with COPD Source: International Congress 2014 – Basic and translational research in asthma and COPD Year: 2014 Expression of estrogen receptors and estrogen metabolism genes in lungs of COPD patients Source: International Congress 2015 – Inflammation and remodelling in lung disease Year: 2015 IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Altered P2 receptor expression profile in sputum cells of patients with COPD Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Mapping of eosinophil and basophils in COPD lung tissues Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 Expression of vascular remodeling markers in relation to bradykinin receptors in asthma and COPD Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases Year: 2013 The role of chemokine receptors in the aberrant migration of COPD neutrophils Source: International Congress 2014 – Cell biology 2014 Year: 2014 Distinct localization of estrogen receptors in lungs of severe COPD patients Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Alterations of the soluble proteome of airway epithelial cells in COPD Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013 Telomere attrition in circulating white blood cells in COPD relates to lung function and outcomes Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD) Year: 2014 Neutrophil numbers are decreased in bronchial biopsies from patients with COPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Relationship between monocyte-derived macrophage phagocytosis and airway inflammation in stable COPD Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 TNFalpha release by monocyte-derived macrophages at stable and exacerbation states in COPD Source: International Congress 2014 – COPD physiopathology Year: 2014 PTX3 a marker of innate immune responses in the airways of asthmatics and COPD patients Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 Relationship of monocyte-derived macrophage phagocytosis to exacerbation susceptibility in stable COPD Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014 Different changes in plasma concentrations of cytokines and chemokines in patients with COPD associated with smoking and occupational exposures Source: International Congress 2016 – Human responses to exposure, including physiological and biomarker outcomes Year: 2016